These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14524578)

  • 1. Association between blood indoxyl sulfate and carbonyl stress marker in hemodialysis patients.
    Kato A; Odamaki M; Hishida A
    Clin Nephrol; 2003 Sep; 60(3):161-7. PubMed ID: 14524578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indoxyl sulfate and atherosclerotic risk factors in hemodialysis patients.
    Taki K; Tsuruta Y; Niwa T
    Am J Nephrol; 2007; 27(1):30-5. PubMed ID: 17215572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of "carbonyl stress".
    Jadoul M; Ueda Y; Yasuda Y; Saito A; Robert A; Ishida N; Kurokawa K; Van Ypersele De Strihou C; Miyata T
    Kidney Int; 1999 Jun; 55(6):2487-92. PubMed ID: 10354298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of hemodialysis membrane permeability on serum levels of advanced glycation end products (AGEs) and homocysteine metabolites.
    Klemm A; Franke C; Busch M; Müller A; Franke S; Lang D; Passlick-Deetjen J; Stein G
    Clin Nephrol; 2004 Mar; 61(3):191-7. PubMed ID: 15077870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of protein leaking BK-F PMMA-based hemodialysis on plasma pentosidine levels.
    Tessitore N; Lapolla A; Aricò NC; Poli A; Gammaro L; Bassi A; Bedogna V; Corgnati A; Reitano R; Fedele D; Lupo A
    J Nephrol; 2004; 17(5):707-14. PubMed ID: 15593039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress, advanced glycation end product, and coronary artery calcification in hemodialysis patients.
    Taki K; Takayama F; Tsuruta Y; Niwa T
    Kidney Int; 2006 Jul; 70(1):218-24. PubMed ID: 16723988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of serum pentosidine with arterial stiffness in hemodialysis patients.
    Zhou Y; Yu Z; Jia H; Sun F; Ma L; Guo R; Peng L; Cui T
    Artif Organs; 2010 Mar; 34(3):193-9. PubMed ID: 20447043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of dialysis membrane type on plasma concentrations of pentosidine, a marker of carbonyl stress, in hemodialyzed patients.
    Słowik-Zyłka D; Safranow K; Dziedziejko V; Ciechanowski K; Dziewanowski K; Chlubek D
    Pol Arch Med Wewn; 2009 Oct; 119(10):614-20. PubMed ID: 19847136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked increases in macrophage colony-stimulating factor and interleukin-18 in maintenance hemodialysis patients: comparative study of advanced glycation end products, carboxymethyllysine and pentosidine.
    Uchimura T; Motomiya Y; Okamura H; Hashiguchi T; Miura M; Uji Y; Iwamoto H; Maruyama I
    Nephron; 2002 Apr; 90(4):401-7. PubMed ID: 11961398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study.
    Piroddi M; Palazzetti I; Quintaliani G; Pilolli F; Montaldi M; Valentina V; Libetta C; Galli F
    J Ren Nutr; 2011 Jul; 21(4):329-39. PubMed ID: 21193322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end products: specific fluorescence changes of pentosidine-like compounds during short daily hemodialysis.
    Fagugli RM; Vanholder R; De Smet R; Selvi A; Antolini F; Lameire N; Floridi A; Buoncristiani U
    Int J Artif Organs; 2001 May; 24(5):256-62. PubMed ID: 11420874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of gender, weight, height and BMI on pentosidine concentrations in plasma of hemodialyzed patients.
    Slowick-Zylka D; Safranow K; Dziedziejko V; Dutkiewicz G; Ciechanowski K; Chlubek D
    J Nephrol; 2006; 19(1):65-9. PubMed ID: 16523428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma pentosidine levels measured by a newly developed method using ELISA in patients with chronic renal failure.
    Sanaka T; Funaki T; Tanaka T; Hoshi S; Niwayama J; Taitoh T; Nishimura H; Higuchi C
    Nephron; 2002 May; 91(1):64-73. PubMed ID: 12021521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease.
    Machowska A; Sun J; Qureshi AR; Isoyama N; Leurs P; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
    PLoS One; 2016; 11(10):e0163826. PubMed ID: 27701453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between pentosidine and hemodialysis-related connective tissue disorders.
    Sakata S; Takahashi M; Kushida K; Oikawa M; Hoshino H; Denda M; Inoue T
    Nephron; 1998; 78(3):260-5. PubMed ID: 9546683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma protein pentosidine and carboxymethyllysine, biomarkers for age-related macular degeneration.
    Ni J; Yuan X; Gu J; Yue X; Gu X; Nagaraj RH; Crabb JW;
    Mol Cell Proteomics; 2009 Aug; 8(8):1921-33. PubMed ID: 19435712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
    Schiel R; Franke S; Busch M; Müller A; Fleck C; Müller UA; Braun A; Stein G
    Eur J Med Res; 2003 Jul; 8(7):283-91. PubMed ID: 12911864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between pentosidine and arteriosclerosis in patients receiving hemodialysis.
    Kitauchi T; Yoshida K; Yoneda T; Saka T; Yoshikawa M; Ozono S; Hirao Y
    Clin Exp Nephrol; 2004 Mar; 8(1):48-53. PubMed ID: 15067516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are advanced glycation end products cardiovascular risk factors in patients with CRF?
    Stein G; Busch M; Müller A; Wendt T; Franke C; Niwa T; Franke S
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S52-6. PubMed ID: 12612953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients.
    Honda H; Hosaka N; Aoshima Y; Hirai Y; Michihata T; Akizawa T
    Clin Exp Hypertens; 2012; 34(1):17-23. PubMed ID: 22149003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.